ESK
Etherstack PLC
🇦🇺 ASX
📈 HIGH PRICE GROWTH
🤖 TECHNOLOGY
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 16.76%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Etherstack Plc engages in the design, development, and deployment of wireless communications software and products. The company is headquartered in Reading, Berkshire and currently employs 40 full-time employees. The company went IPO on 2012-09-07. The firm develops software for use in transceivers which enable the transceiver to communicate with a radio network and other transceivers. The company develops network soft switching software that allows network services to be deployed in data centers such as those used by telecommunications carriers. The company also licenses its software and designs to companies who manufacture telecommunication equipment primarily for government public safety agencies and utilities. Its technology and systems include cryptography and key management, defense waveforms, LMR - LTE Interworking, LMR Protocol Stacks, LMR Voice and Data Systems and Tactical and Satellite Systems. The company provides a range of cryptographic solutions that includes FIPS 140-2 Cryptographic Module and P25 Security Dongle.
📈 Performance
Price History
+25.67%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.34
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ESK
1
📊 Total Capital Earnings
$3K
🔃 Average investment frequency
8 weeks
💵 Average investment amount
$2,285
⏰ Last time a customer invested in ESK
221 days
ESK investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
100%
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
100%
35 - 90
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in ESK also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
2.99%
📊 Share price
$101.87 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
🧱 MATERIALS
⛳️ DIVERSIFIED
Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-02-13. The firm is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).
🙌 Performance (5Yr p.a)
-10.65%
📊 Share price
$11.28 AUD
🧬 BIOTECHNOLOGY
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
12.66%
📊 Share price
$141.13 AUD
🤖 TECHNOLOGY
🌏 GLOBAL
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).
🙌 Performance (5Yr p.a)
11.47%
📊 Share price
$88.44 AUD
🌏 GLOBAL
🛍️ CONSUMER
📈 HIGH PRICE GROWTH
🏭 INDUSTRIALS
ClearVue Technologies Ltd. engages in the provision of photovoltaic and nano-technology to produce clear glass that generates electricity. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-05-25. The firm operates in the building sustainability solutions sector supplying glazing products responding to the global need for construction decarbonization in a world where buildings and construction contribute nearly 40% of global greenhouse gas emissions. The Company’s solar photovoltaic glazing integrates solar technology into glass and building surfaces helping building owners to reach net zero through the generation of on-site electricity whilst at the same time improving the energy efficiency of the building envelope. The firm provides glazing solutions to various areas, including construction, greenhouses, utilities and infrastructure and demonstrations / research and development. Its products include Clear solar windows, Clear self-powered smart autonomous windows, Clear solar glass greenhouse, Self-powered illuminating facades, and Imaged solar windows.
🙌 Performance (5Yr p.a)
7.59%
📊 Share price
$0.20 AUD
🔨 COMMERCIAL SERVICES & SUPPLIES
Want more shares? Try these...
